Compelling pre clinical results with compete eradication of all tumours in mice for 7 cancer lines and no reoccurrence
Car T was developed by the University of Pennsylvania. They are generally recognised as the pioneers of Car-T therapy
Only 3 companies are developing therapies targeting CDH17, and we are the ONLY company with Car T in the clinic (soon) and a NK CDH17 in preclinical trial
Gastric, colorectal and NED cancers represent some of the largest oncology segments with single digit to low teen 5 year survival rates - ie huge markets with unmet needs
There are over 5+ million gastric cancer diagnoses annually
CDH17 is a novel antigen that has only recently been attracting attention as a potential cancer target. CD19 and BCMA have been the main antigens targeted by by biotech companies for blood cancers over the last few years.
Paul Hopper was quoted a few years ago as saying that licensing CDH17 Car T from the University of Pennsylvania was one of the best deals he has ever inked in the biotech space.
CDH 17 Car T featured on the cover of Nature Oncology vaccine so it has been rigorously reviewed and independently verified
If the CDH17 Car T works then the NK therapy will also attract a huge valuation
CDH17 Car T is targeting solid tumours and is poised to be the first Car T to demonstrate amazing efficacy like the CD19 B cell blood cancers
Big pharma will be watching the progress on this trial very closely.
So watch this space!!
- Forums
- ASX - By Stock
- CDH17 Car T therapy has blockbuster potential
Compelling pre clinical results with compete eradication of all...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.7¢ | $9.826K | 570.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3159986 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 94135 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3101163 | 0.017 |
11 | 1671109 | 0.016 |
8 | 1593116 | 0.015 |
3 | 2575142 | 0.014 |
1 | 200000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 308339 | 5 |
0.020 | 613093 | 8 |
0.021 | 282857 | 2 |
0.022 | 603767 | 4 |
0.023 | 250000 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |